These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30907328)

  • 1. Nanotechnology in Insulin Delivery for Management of Diabetes.
    Bahman F; Greish K; Taurin S
    Pharm Nanotechnol; 2019; 7(2):113-128. PubMed ID: 30907328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of biodegradable polymeric systems for oral insulin delivery.
    Luo YY; Xiong XY; Tian Y; Li ZL; Gong YC; Li YP
    Drug Deliv; 2016 Jul; 23(6):1882-91. PubMed ID: 26066036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
    Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes management strategies: can nanoparticles be used to therapeutically deliver insulin?
    Mazzucchelli S; Corsi F
    Ther Deliv; 2017 Feb; 8(2):49-51. PubMed ID: 28088882
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities.
    Wong CY; Martinez J; Dass CR
    J Pharm Pharmacol; 2016 Sep; 68(9):1093-108. PubMed ID: 27364922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral insulin delivery: existing barriers and current counter-strategies.
    Gedawy A; Martinez J; Al-Salami H; Dass CR
    J Pharm Pharmacol; 2018 Feb; 70(2):197-213. PubMed ID: 29193053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle strategies for the oral delivery of insulin.
    Damgé C; Reis CP; Maincent P
    Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.
    Wong CY; Al-Salami H; Dass CR
    J Control Release; 2017 Oct; 264():247-275. PubMed ID: 28887133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface engineering of silica nanoparticles for oral insulin delivery: characterization and cell toxicity studies.
    Andreani T; Kiill CP; de Souza AL; Fangueiro JF; Fernandes L; Doktorovová S; Santos DL; Garcia ML; Gremião MP; Souto EB; Silva AM
    Colloids Surf B Biointerfaces; 2014 Nov; 123():916-23. PubMed ID: 25466464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered nanoparticles in non-invasive insulin delivery for precision therapeutics of diabetes.
    Adwani G; Bharti S; Kumar A
    Int J Biol Macromol; 2024 Aug; 275(Pt 1):133437. PubMed ID: 38944087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, and in vitro studies of PLGA-PEG nanoparticles for oral insulin delivery.
    Hosseininasab S; Pashaei-Asl R; Khandaghi AA; Nasrabadi HT; Nejati-Koshki K; Akbarzadeh A; Joo SW; Hanifehpour Y; Davaran S
    Chem Biol Drug Des; 2014 Sep; 84(3):307-15. PubMed ID: 24684797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.
    Li L; Jiang G; Yu W; Liu D; Chen H; Liu Y; Tong Z; Kong X; Yao J
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):278-286. PubMed ID: 27770892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to overcome the limitations of current insulin administration with new non-invasive delivery systems.
    Sousa F; Castro P; Fonte P; Sarmento B
    Ther Deliv; 2015 Jan; 6(1):83-94. PubMed ID: 25565442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent patents on oral insulin delivery.
    Navgire SD; Satpute AS; Pandey S; Patil AT
    Recent Pat Drug Deliv Formul; 2014; 8(3):202-5. PubMed ID: 24981288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative routes of insulin delivery.
    Owens DR; Zinman B; Bolli G
    Diabet Med; 2003 Nov; 20(11):886-98. PubMed ID: 14632713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of alternative insulin delivery systems.
    Strack T
    Curr Opin Investig Drugs; 2010 Apr; 11(4):394-401. PubMed ID: 20336587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developments in polymeric devices for oral insulin delivery.
    Babu VR; Patel P; Mundargi RC; Rangaswamy V; Aminabhavi TM
    Expert Opin Drug Deliv; 2008 Apr; 5(4):403-15. PubMed ID: 18426382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel strategies to oral delivery of insulin: Current progress of nanocarriers for diabetes management.
    Abdel-Moneim A; Ramadan H
    Drug Dev Res; 2022 Apr; 83(2):301-316. PubMed ID: 34859477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.